700 patients reviewed: are minimally invasive tumor removals effective Long-Term?
NCT ID NCT07353346
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks back at 700 patients who had endoscopic treatment for gastrointestinal submucosal tumors at Xijing Hospital. Researchers want to know how often the tumors are completely removed, what complications occur, and whether the tumors come back over time. The goal is to provide clearer guidance for doctors choosing the best treatment approach.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- endoscopic procedures (EMR, ESE, STER, EFR)
- What this could lead to
- If successful, this could help doctors choose the best endoscopic method for removing gastrointestinal tumors, leading to more personalized care.
- What could go wrong
- This is a retrospective review, not a controlled trial, so results may be influenced by past record-keeping and patient selection. It cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
700 people
The number who actually took part.
- Started
-
Jan 2012
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who underwent endoscopic treatment for gastrointestinal submucosal tumors at Xijing Hospital from January 1, 2012 to August 1, 2025.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who underwent endoscopic treatment for gastrointestinal submucosal tumors at Xijing Hospital from January 1, 2012 to August 1, 2025. Exclusion Criteria: * Patients with gastrointestinal protruding lesions caused by external compression.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal submucosal tumors are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.